Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design
J. Virol. Gasper-Smith et al.
82: 7700
Supplemental material
Files in this Data Supplement:
- Supplemental file 1
-
Fig. S1 (Histograms showing distribution of times elapsed between consecutive donations and total data points.)
Fig. S2 (Development of flow cytometric techniques for measurement of plasma MP.)
Fig. S3 (Effects of freeze-thaw cycles on the phenotype of plasma MPs.)
Table S1 (Timing of plasma analyte maximum values relative to maximum viral load.)
Table S2 (Relationship of relative plasma microparticle counts to plasma viral loads.)
Table S3 (Ratio of relative plasma MP counts to plasma viral loads.)
Word document, 1.8MB
